MedPath

Investigation of the effect of rivastigmine patch on gait disturbance in patients with Alzheimer disease. Clinical study (intervention study).

Not Applicable
Conditions
Alzheimer disease
Registration Number
JPRN-UMIN000025869
Lead Sponsor
Juntendo University Urayasu Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with obvious motor disability Patients who can not administer rivastigmine patch

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
gait speed, gait speed on dual task at 4weeks and 12 weeks after therapy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath